KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Current Liabilities (2016 - 2025)

West Pharmaceutical Services' Total Current Liabilities history spans 17 years, with the latest figure at $654.9 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 18.99% year-over-year to $654.9 million; the TTM value through Dec 2025 reached $654.9 million, up 18.99%, while the annual FY2025 figure was $654.9 million, 18.99% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $654.9 million at West Pharmaceutical Services, up from $635.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $671.8 million in Q4 2023 and bottomed at $456.7 million in Q3 2022.
  • The 5-year median for Total Current Liabilities is $554.5 million (2021), against an average of $562.8 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 40.19% in 2021 before it dropped 18.77% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $594.1 million in 2021, then dropped by 12.64% to $519.0 million in 2022, then grew by 29.44% to $671.8 million in 2023, then dropped by 18.07% to $550.4 million in 2024, then grew by 18.99% to $654.9 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Total Current Liabilities are $654.9 million (Q4 2025), $635.4 million (Q3 2025), and $604.6 million (Q2 2025).